Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Liabilities and Shareholders Equity (2020 - 2026)

MDxHealth has reported Liabilities and Shareholders Equity over the past 7 years, most recently at $160.8 million for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $160.8 million; the TTM value through Mar 2026 reached $466.1 million, up 14.92%, while the annual FY2025 figure was $148.0 million, 5.96% down from the prior year.
  • Liabilities and Shareholders Equity was $160.8 million for Q1 2026 at MDxHealth, up from $148.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $160.8 million in Q1 2026 and bottomed at $119.1 million in Q4 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $148.0 million (2025), against an average of $142.9 million.
  • Year-over-year, Liabilities and Shareholders Equity soared 58.69% in 2022 and then decreased 5.96% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $119.1 million in 2022, then increased by 8.39% to $129.1 million in 2023, then rose by 21.84% to $157.3 million in 2024, then fell by 5.96% to $148.0 million in 2025, then increased by 8.7% to $160.8 million in 2026.
  • The last three reported values for Liabilities and Shareholders Equity were $160.8 million (Q1 2026), $148.0 million (Q4 2025), and $157.3 million (Q4 2024) per Business Quant data.